CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays

Journal of Immunological Methods

Volumn 278, Issue 1-2, 2003, Pages 79-93

  Kreher, Christian R ^a,b   Dittrich, Markus T ^a   Guerkov, Robert ^a   Boehm, Bernhard O ^b   Tary Lehmann, Magdalena ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

CD4+; CD8+; Cryopreservation; ELISPOT; Th1; Th2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CRYOPRESERVATION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; IMMUNOASSAY; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; THAWING;

MURINAE;

EID: 0142071152     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(03)00226-6     Document Type: Article

References (32)

1. Agarwal S., Rao A. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity. 9:1998;765-775.
2. Areman E.M., Simonis T.B., Carter C.S., Read E.J., Klein H.G. Bulk cryopreservation of lymphocytes in glycerol. Transfusion. 28:1988;151-156.
3. Barouch D.H., Letvin N.L. CD8+ cytotoxic T lymphocyte responses to lentiviruses and herpesviruses. Curr. Opin. Immunol. 13:2001;479-482.
4. Bucy R.P., Panoskaltsis-Mortari A., Huang G.Q., Li J., Karr L., Ross M., Russell J.H., Murphy K.M., Weaver C.T. Heterogeneity of single cell cytokine gene expression in clonal T cell populations. J. Exp. Med. 180:1994;1251-1262.
5. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186:1997;1623-1631.
6. Cillari E., Liew F.Y., Lo C.P., Milano S., Mansueto S., Salerno A. Suppression of IL-2 production by cryopreserved peripheral blood mononuclear cells from patients with active visceral leishmaniasis in Sicily. J. Immunol. 140:1988;2721-2726.
7. Cottrez F., Hurst S.D., Coffman R.L., Groux H. T regulatory cells 1 inhibit a Th2-specific response in vivo. J. Immunol. 165:2000;4848-4853.
8. Currier J.R., Kuta E.G., Turk E., Earhart L.B., Loomis-Price L., Janetzki S., Ferrari G., Birx D.L., Cox J.H. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J. Immunol. Methods. 260:2002;157-172.
9. Forsthuber T., Yip H.C., Lehmann P.V. Induction of TH1 and TH2 immunity in neonatal mice. Science. 271:1996;1728-1730.
10. Fremont D.H., Stura E.A., Matsumura M., Peterson P.A., Wilson I.A. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc. Natl. Acad. Sci. U. S. A. 92:1995;2479-2483.
11. Heeger P.S., Valujskikh A., Lehmann P.V. Comprehensive assessment of determinant specificity, frequency, and cytokine signature of the primed CD8 cell repertoire induced by a minor transplantation antigen. J. Immunol. 165:2000;1278-1284.
12. Helms T., Boehm B.O., Asaad R.J., Trezza R.P., Lehmann P.V., Tary-Lehmann M. Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients. J. Immunol. 164:2000;3723-3732.
13. Hesse M.D., Karulin A.Y., Boehm B.O., Lehmann P.V., Tary-Lehmann M. A T cell clone's avidity is a function of its activation state. J. Immunol. 167:2001;1353-1361.
14. Jung T., Schauer U., Rieger C., Wagner K., Einsle K., Neumann C., Heusser C. Interleukin-4 and interleukin-5 are rarely co-expressed by human T cells. Eur. J. Immunol. 25:1995;2413-2416.
15. Karulin A.Y., Hesse M.D., Tary-Lehmann M., Lehmann P.V. Single-cytokine-producing CD4 memory cells predominate in type 1 and type 2 immunity. J. Immunol. 164:2000;1862-1872.
16. Kelso A. Th1 and Th2 subsets: paradigms lost? Immunol. Today. 16:1995;374-379.
17. Kelso A., Groves P., Troutt A.B., Francis K. Evidence for the stochastic acquisition of cytokine profile by CD4+ T cells activated in a T helper type 2-like response in vivo. Eur. J. Immunol. 25:1995;1168-1175.
18. McCutcheon M., Wehner N., Wensky A., Kushner M., Doan S., Hsiao L., Calabresi P., Ha T., Tran T.V., Tate K.M., Winkelhake J., Spack E.G. A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. J. Immunol. Methods. 210:1997;149-166.
19. McMichael A.J., O'Callaghan C.A. A new look at T cells. J. Exp. Med. 187:1998;1367-1371.
20. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
21. Smith J.G., Liu X., Kaufhold R.M., Clair J., Caulfield M.J. Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus. Clin. Diagn. Lab. Immunol. 8:2001;871-879.
22. Sobota V., Bubenik J., Indrova M., Vlk V., Jakoubkova J. Use of cryopreserved lymphocytes for assessment of the immunological effects of interferon therapy in renal cell carcinoma patients. J. Immunol. Methods. 203:1997;1-10.
23. Tanguay S., Killion J.J. Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells. Lymphokine Cytokine Res. 13:1994;259-263.
24. Tary-Lehmann M., Saxon A. Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J. Exp. Med. 175:1992;503-516.
25. Venkataraman M. Effects of cryopreservation on immune responses: VIII. Enhanced secretion of interferon-gamma by frozen human peripheral blood mononuclear cells. Cryobiology. 32:1995;528-534.
26. Wang S.Y., Hsu M.L., Tzeng C.H., Hsu H.C., Ho C.K. The influence of cryopreservation on cytokine production by human T lymphocytes. Cryobiology. 37:1998;22-29.
27. Weinberg A., Betensky R.A., Zhang L., Ray G. Effect of shipment, storage, anticoagulant, and cell separation on lymphocyte proliferation assays for human immunodeficiency virus-infected patients. Clin. Diagn. Lab. Immunol. 5:1998;804-807.
28. Whiteside T.L. Immunologic monitoring of clinical trials in patients with cancer: technology versus common sense. Immunol. Invest. 29:2000;149-162.
29. Wolfe J., Bryant G. Freezing, drying, and/or vitrification of membrane-solute-water systems. Cryobiology. 39:1999;103-129.
30. Yip H.C., Karulin A.Y., Tary-Lehmann M., Hesse M.D., Radeke H., Heeger P.S., Trezza R.P., Heinzel F.P., Forsthuber T., Lehmann P.V. Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J. Immunol. 162:1999;3942-3949.
31. Yokoyama W.M. Cryopreservation of cells. Coligan J.E., Kruisbeek A.M., Margulies D.H., Shevach E.M., Strober W. Current Protocols in Immunology. 1997;A.3.G.1-A.3.G.3 Wiley, New York.
32. Yu Z.W., Quinn P.J. The modulation of membrane structure and stability by dimethyl sulphoxide. Mol. Membr. Biol. 15:1998;59-68.